Characterisation of seven human ovarian tumour cell lines

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 722-727

  Wilson, A P ^a   Dent, M ^a   Pejovic, T ^b   Hubbold, L ^a   Radford, H ^a  

^a DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Characterisation; Heterogeneity; Karyotype; Ovarian tumour line

Indexed keywords

KERATIN; VIMENTIN;

ARTICLE; CHROMOSOME 11P; CLONOGENESIS; DESMOSOME; HUMAN; HUMAN CELL; OVARY TUMOR; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029738932     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.428     Document Type: Article

References (23)

1. ECCLES DM, GRUBER L, STEWART M, STEEL LM AND LEONARD RCF. (1992). Allele loss on chromosome 11p is associated with poor survival in ovarian cancer. Dis. Markers, 10, 95-99.
2. EHLEN T AND DUBEAU L. (1990). Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene, 5, 219-223.
3. FENOGLIO CM. (1980). Overview article: ultrastructural features of the common epithelial tumours of the ovary. Ultrastructural Pathol., 1, 419-444.
4. FROMM G-L, GERSHENSON DM AND SILVA EG. (1990). Papillary serous carcinoma of the peritoneum. Obstet. Gynecol., 75, 89-95.
5. HILL SM, RODGERS CS, HULTEN MA AND WILSON AP. (1984). Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma. Cancer Genet. Cytogenet., 12, 321-327.
6. HILLS CA, KELLAND LR, ABEL G, SIRACKY J, WILSON AP AND HARRAP KR. (1989). Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes. Br. J. Cancer, 59, 527-534.
7. ISCN. (1991). Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Mitelman F. (ed.), S. Karger: Basel.
8. ISHIWATA I, ISHIWATA C, SOMA M AND ISHIKAWA H. (1986). Establishment and characterisation of two human ovarian endometroid carcinoma cell lines (with or without squamous cell component). Gynaecol. Oncol., 25, 95-107.
9. ISHIWATA I, ISHIWATA C, SOMA M AND ISHIKAWA H. (1987a). Establishment of HVOCA-11, a human ovarian clear cell adenocarcinoma cell line and its angiogenic activity. J. Natl Cancer Inst., 78, 667-673.
10. ISHIWATA I, ISHIWATA C, SOMA M, NOZAWA S AND ISHIKAWA H. (1987b). Characterisation of newly established human ovarian carcinoma cell line - special reference of the effects of cis-platinum on cellular proliferation and release of CA125. Gynaecol. Oncol., 26, 340-354.
11. ISHIWATA I, ISHIWATA C, SOMA M, ONO I, NAKAGUCHI T AND ISHIKAWA H. (1988). Establishment and characterisation of a human ovarian anaplastic carcinoma cell line. Gynaecol. Oncol., 30, 35-43.
12. KABAWAT SE, BAST RC, BHAN K, WELCH WR, KNAPP RC AND COLVIN RB. (1983). Tissue distribution of a coelomic-epithelium-related antigen recognised by the monoclonal antibody OC 125. Int. J. Gynaecol. Pathol, 2, 275-285.
13. LANGDON SP, LAWRIE SS, HAY FG, HAWKES MM, MCDONALD A, HAYWARD IP, SCHOL DJ, HILGERS J, LEONARD RCF AND SMYTH JF. (1988). Characterisation and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res., 48, 6166-6172.
14. MITELMAN F. (1991). Catalog of Chromosome Aberrations in Cancer. 4th ed. pp. 2056, Wiley-Liss: New York.
15. MOBUS V, GERHARZ CD, PRESS U, MOU R, BECK T, MELLIN W, POLLOW K, KNAPSTEIN PG AND KREIENBERG R. (1992). Morphological immunohistochemical and biochemical characterisation of 6 newly established human ovarian carcinoma cell lines. Int. J. Cancer, 52, 76 84.
16. MOLL R, FRANKE WW, SCHILLER DL, GEIGER B AND KREPLER R. (1982). The catalog of human cytokeratins. Patterns of expression in normal epithelia, tumors and cultured cells. Cell, 31, 11-24.
17. PEJOVIC T, HIM S, MANDAHL N, BALDETORP B, ELMFORS B, FLODERUS U-M, FURGYIK S, HELM G, HIMMELMANN A, WILLEN H AND MITELMAN F. (1992). Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chrom. Cancer, 4, 58 68.
18. SATO T, SAITO H, MORITA R, KOI S, LEE JH AND NAKAMURA Y. (1991). Allelotype of human ovarian cancer. Cancer Res., 51, 5118-5122.
19. SIMON WE, ALBRECHT M, HASSEL M, DIETEL M AND HOLZER F. (1983). Cell lines derived from human ovarian carcinomas, growth stimulation by gonadotrophic and steroid hormones. J. Natl Cancer Inst., 70, 839-845.
20. VANDAMME B, LISSERS W, AMFO K, DE SUTTER P, BOURGAIN C, VAMOS E AND DE GRÈVE J. (1992). Deletion of chromosome 11p13-11p15.5. Sequences in invasive human ovarian cancer is a subclonal progression factor. Cancer Res., 52, 6646 6652.
21. VIEL A, GIANNINI F, TUMIOTTO L, SOPRACORDEVOLE F, VISENTIN MC AND BOIOCCHI M. (1992). Chromosomal localisation of two putative lip oncosuppressor genes involved in human ovarian tumours. Br. J. Cancer, 66, 1030 1036.
22. WILSON AP. (1984). Characterisation of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary. J. Natl Cancer Inst., 72, 513-521.
23. WILSON AP. (1987). In vitro fibrin formation by ascitic and peritoneal fluids: a novel system for the study of fibrin cell interactions. Br. J. Cancer, 56, 206.